Biotech & Health Tech
STAT+: Pharmalittle: We’re reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more
Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements
Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗